Paul J Merrigan
CIK 1653275 · View on SEC EDGAR ↗
First SEC filing: Oct. 9, 2015 · Latest: Oct. 9, 2015
On this page
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Dec. 30, 2015 | CPRX | A | 50,000 | — | — | 300,000 Direct | +20.00% | Acquired | |
| Dec. 30, 2015 | CPRX | A | 50,000 | — | — | 250,000 Direct | +25.00% | Acquired | |
| Dec. 30, 2015 | CPRX | A | 50,000 | — | — | 200,000 Direct | +33.33% | Acquired |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Dec. 30, 2015 | CPRX | Options to purchase common stock | Common Stock (50,000) | $2.53 | Dec. 30, 2022 | 50,000 | Acquired |
| Dec. 30, 2015 | CPRX | Options to purchase common stock | Common Stock (50,000) | $2.53 | Dec. 30, 2022 | 50,000 | Acquired |
| Dec. 30, 2015 | CPRX | Options to purchase common stock | Common Stock (50,000) | $2.53 | Dec. 30, 2022 | 50,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 6 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Oct. 9, 2015 | CPRX | Options to purchase common stock→ Common Stock (50,000) | 50,000 | Direct |
| Oct. 9, 2015 | CPRX | Options to purchase common stock→ Common Stock | — | Direct |
| Oct. 9, 2015 | CPRX | Options to purchase common stock→ Common Stock (4,159) | 4,159 | Direct |
| Sept. 16, 2015 | CPRX | Options to purchase common stock→ Common Stock (50,000) | 50,000 | Direct |
| Sept. 16, 2015 | CPRX | Options to purchase common stock→ Common Stock | — | Direct |
| Sept. 16, 2015 | CPRX | Options to purchase common stock→ Common Stock (4,159) | 4,159 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
CIK 1369568
former Chief Commercial Officer (5)| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2016 | $32,000,098,750 | — | — | — | — | — | — | — |
| 2015 | $98,750 | — | — | — | — | — | — | — |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.